Firm gets FDA approval for SPECT/CT imaging system

03/26/2009 | AuntMinnie.com (free registration)

The FDA has given 510(k) clearance to Digirad to market its Cardius X-ACT imaging system. The cardiac SPECT/CT device is capable of low-dose VCT attenuation correction to limit image artifacts caused by overlying tissues. It features a 24-inch-wide detector array and triple-head solid-state digital detectors.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA